EVATRAN (The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients): study protocol for a cross-over randomized controlled trial
Authors
Erwan Bozec
Nicolas Girerd (ORCID: https://orcid.org/0000-0002-3278-2057)
Sophie Girerd (ORCID: https://orcid.org/0000-0001-9303-7184)
EVATRAN (The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients): study protocol for a cross-over randomized controlled trial
Erwan Bozec, Nicolas Girerd, Sophie Girerd, Arnaud Simon et al.
Journal
Trials
Topics
Renal and Vascular Pathologies
article
EVATRAN (The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients): study protocol for a cross-over randomized controlled trial
Erwan Bozec, Nicolas Girerd, Sophie Girerd, Arnaud Simon, Ludovic Mercklé, Frédéric Jaisser, Luc Frimat, Xavier Lepage, Patrick Rossignol
article en
Abstract
No abstract available for this paper.
Publication Tag
TrialsVol. 26(1)
Institutions
Inserm (FR), Université Paris Cité (FR), Centre de Recherche des Cordeliers (FR), Centre Hospitalier Régional et Universitaire de Nancy (FR), Centre d’Investigation Clinique Innovation Technologique de Nancy (FR), Délégation Centre-Est (FR), Université de Lorraine (FR)